Herbert H. Engelhard

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

Roger Stupp, Sophie Taillibert, Andrew A. Kanner et al. · JAMA · 2015 · 1.2K citations · Full text

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Roger Stupp, Eric T. Wong, Andrew A. Kanner et al. · European Journal of Cancer · 2012 · 828 citations

Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina

Herbert H. Engelhard, John L. Villano, Kimberly R. Porter et al. · Journal of Neurosurgery Spine · 2010 · 219 citations

Surgical Oncology, Clinical Presentation, Pathology +18

Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries

Bridget J. McCarthy, Soichiro Shibui, Takamasa Kayama et al. · Neuro-Oncology · 2012 · 169 citations · Full text

Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe)

Maciej M. Mrugała, Herbert H. Engelhard, David Tran et al. · Seminars in Oncology · 2014 · 143 citations · Full text

Surgical Oncology, Cancer Management, Cancer Registration +21